Comparison of the efficacy and adverse effects of sustained-release buprenorphine hydrochloride following subcutaneous administration and buprenorphine hydrochloride following oral transmucosal administration in cats undergoing ovariohysterectomy

American Journal of Veterinary Research

Volumn 72, Issue 4, 2011, Pages 461-466

  Catbagan, Davina L ^a   Quimby, Jessica M ^a   Mama, Khursheed R ^a   Rychel, Jessica K ^a   Mich, Patrice M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DIAZEPAM; ISOFLURANE; KETAMINE; MELOXICAM; NARCOTIC ANALGESIC AGENT; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CAT; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; FEMALE; HEART RATE; HYSTERECTOMY; MUCOSAL ADMINISTRATION; NONHUMAN; PAIN ASSESSMENT; PHYSIOLOGY; POSTOPERATIVE PERIOD; SUSTAINED RELEASE FORMULATION; TEMPERATURE; ANIMAL; ANIMAL DISEASE; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; OVARIECTOMY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

ADMINISTRATION, MUCOSAL; ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; CATS; DELAYED-ACTION PREPARATIONS; FEMALE; HEART RATE; HYSTERECTOMY; INJECTIONS, SUBCUTANEOUS; OVARIECTOMY; PAIN MEASUREMENT; TEMPERATURE; THIAZINES; THIAZOLES;

EID: 79955547163     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.4.461     Document Type: Article

References (12)

1. Robertson SA, Taylor PM, Sear J W. Systemic uptake of bu-prenorphine by cats after oral mucosal administration. Vet Rec 2003;152:675-678.
2. Robertson SA, Lascelles BDX, Dixon MJ. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration. J Vet Pharm Ther 2005;28:453-460.
3. Robertson SA, Taylor PM, Lascelles BDX, et al. Changes in thermal thresholds responses in eight cats after administration of buprenorphine, butorphanol and morphine. Vet Rec 2003;153:462-465.
4. Steagall PVM, Mantovani FB, Taylor PM, et al. Dose-related anti-nociceptive effects of intravenous buprenorphine in cats. Vet J 2009;182:203-209.
5. Quimby JM, Olea-Popelka F, Lappin M. Comparison of digital rectal and microchip transponder thermometry in cats. J Am As-soc Lab Anim Sci 2009;48:1-4.
6. Hanwei Z, Cui Wenjin, Jainzhong B, et al. Preparation of poly(lactide-co-glycolide-co-caprolactone) nanoparticles and their degradation behaviour in aqueous solution. Polym Degradation Stab 2006;91:1929-1936.
7. Dunn RL, Yewey GL, Fujita SM, et al. Sustained release of cispl-atin in dogs from an injectable implant delivery system. J Bioact Compatible Polym 1996;11:286-300.
8. Giraudel JM, Diquelou A, Laroute V, et al. Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs. J Vet Pharm Therap 2005;28:275-285.
9. Shih AC, Robertson S, Isaza N, et al. Comparison between analgesic effects of buprenorphine, carprofen, and buprenorphine with carprofen for canine ovariohysterectomy. Vet Anaesth Analg 2008;35:69-79.
10. KuKanich B, Duncan BX, Papich MG. Assessment of a von Frey device for evaluation of the antinociceptive effects of morphine and its application in pharmacodynamic modeling of morphine in dogs. Am J Vet Res 2005;66:1616-1622.
11. Slingsby LS, Waterman-Pearson AE. Postoperative analgesia in the cat after ovariohysterectomy by use of carprofen, ke-toprofen, meloxicam or tolfenamic acid. J Small Anim Pract 2000;4:447-450.
12. Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 2001;12:1153-1157.